JP Morgan 2025: analysts remain doubtful of Illumina’s growth
It’s been a busy week for Illumina at the JP Morgan 2025 Healthcare conference, with the company revealing partnerships and …
Post
-
-
FDA grants clearance to icotec’s BlackArmor implants to treat spinal infection
The US Food and Drug Administration (FDA) has granted clearance to icotec for the use of its BlackArmor implants in …
-
JP Morgan 2025: Zimmer Biomet bullish on a strong market return in 2025
Zimmer Biomet expressed its optimism that the company will strengthen its market return in 2025 during the JP Morgan Healthcare …
-
WHO reports eight deaths from suspected Marburg outbreak in Tanzania
Eight people have likely died from an outbreak of Marburg virus disease (MVD) in a northwestern region of Tanzania, according …
-
IMVARIA gains 510(k) clearance for ScreenDx solution for ILD assessment
IMVARIA has gained 510(k) clearance from the US Food and Drug Administration (FDA) for its AI-powered healthcare tool, ScreenDx, designed …
-
Sutter Health partners with GE HealthCare for imaging services
Nonprofit healthcare system Sutter Health has announced a seven-year Care Alliance with GE HealthCare, a medical technology and digital solutions …
-
Samsara reports positive results from SING IMT implantation in AMD patients
Samsara Vision has announced positive intermediate-term visual and safety results from the implantation of the Smaller-Incision New-Generation Implantable Miniature Telescope …
-
Alleviant Medical secures $90m to launch pivotal aortic stent trial
Texas medical device firm Alleviant Medical has secured $90m to fund a second pivotal trial of the company’s heart system …
-
AWS and General Catalyst partner on genAI in healthcare
Amazon Web Services (AWS) and venture capital company General Catalyst have partnered with the aim of strengthening healthcare ecosystems using …
-
JP Morgan 2025: Guardant reports $737m in preliminary full-year revenue
Guardant Health has reported preliminary full-year 2024 revenues of $737m, reflecting year-over-year (YOY) growth of 31%, during an investor presentation …
-
JP Morgan 2025: Dexcom shares up 5% after 2025 outlook forecasts $4.6bn in revenue
Dexcom has shaken off the lower sales outlook that plagued its share price in 2024 as the diabetes device developer …
-
Explainer: Is the UK’s AI blueprint Britain’s path to productivity or simply AI lip service?
The UK government’s blueprint to turbocharge the country’s AI capabilities, announced today (13 Jan), forms a cornerstone of its mission …
-
FDA approves Zeiss Medical Technology’s MEL 90 excimer laser
The US Food and Drug Administration (FDA) has approved Zeiss Medical Technology’s MEL 90 excimer laser technology. MEL 90 is integrated …
-
Illumina and Regeneron invest $139.5m in Truveta to build largest genetic database
DNA sequencing company Illumina and biotech Regeneron have invested in electronic health record data company Truveta to create the largest …
-
Researchers find ctDNA test predicts lung cancer outcomes in study
Researchers from various institutes, along with US biotech company Personalis, have found a test that can predict lung cancer outcomes …
